ArticleJournal of experimental & clinical cancer research : CR2026
Mutant p53 epigenetically rewires CXCL10 to promote CD8⁺ T-cell infiltration and enhance the anti-PD-1 response in advanced prostate cancer.
Jia Chen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.